A citation-based method for searching scientific literature

Shijie Jin, Yanping Sun, Xiao Liang, Xinyu Gu, Jiangtao Ning, Yingchun Xu, Shuqing Chen, Liqiang Pan. Signal Transduct Target Ther 2022
Times Cited: 17







List of co-cited articles
48 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


FDA approves 100th monoclonal antibody product.
Asher Mullard. Nat Rev Drug Discov 2021
116
23

Antibodies to watch in 2021.
Hélène Kaplon, Janice M Reichert. MAbs 2021
144
17

Unlocking the potential of antibody-drug conjugates for cancer therapy.
Joshua Z Drago, Shanu Modi, Sarat Chandarlapaty. Nat Rev Clin Oncol 2021
182
17

Antibody drug conjugate: the "biological missile" for targeted cancer therapy.
Zhiwen Fu, Shijun Li, Sifei Han, Chen Shi, Yu Zhang. Signal Transduct Target Ther 2022
24
17

Strategies and challenges for the next generation of antibody-drug conjugates.
Alain Beck, Liliane Goetsch, Charles Dumontet, Nathalie Corvaïa. Nat Rev Drug Discov 2017
17

Advances and Limitations of Antibody Drug Conjugates for Cancer.
Candice Maria Mckertish, Veysel Kayser. Biomedicines 2021
19
17

FDA approves second BCMA-targeted CAR-T cell therapy.
Asher Mullard. Nat Rev Drug Discov 2022
6
33

Naturally occurring antibodies devoid of light chains.
C Hamers-Casterman, T Atarhouch, S Muyldermans, G Robinson, C Hamers, E B Songa, N Bendahman, R Hamers. Nature 1993
11

IgG subclasses and allotypes: from structure to effector functions.
Gestur Vidarsson, Gillian Dekkers, Theo Rispens. Front Immunol 2014
11



Therapeutic antibodies: successes, limitations and hopes for the future.
Patrick Chames, Marc Van Regenmortel, Etienne Weiss, Daniel Baty. Br J Pharmacol 2009
799
11


Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways.
Lukas Kraehenbuehl, Chien-Huan Weng, Shabnam Eghbali, Jedd D Wolchok, Taha Merghoub. Nat Rev Clin Oncol 2022
79
11

Mechanisms of action of therapeutic antibodies for cancer.
J M Redman, E M Hill, D AlDeghaither, L M Weiner. Mol Immunol 2015
88
11

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.
Laurent Gauthier, Ariane Morel, Nadia Anceriz, Benjamin Rossi, Audrey Blanchard-Alvarez, Gwendoline Grondin, Sylvia Trichard, Cédric Cesari, Melody Sapet, Frédéric Bosco,[...]. Cell 2019
178
11

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.
Spencer C Wei, Colm R Duffy, James P Allison. Cancer Discov 2018
11

Neutralizing monoclonal antibodies for treatment of COVID-19.
Peter C Taylor, Andrew C Adams, Matthew M Hufford, Inmaculada de la Torre, Kevin Winthrop, Robert L Gottlieb. Nat Rev Immunol 2021
297
11

Bispecific antibodies: a mechanistic review of the pipeline.
Aran F Labrijn, Maarten L Janmaat, Janice M Reichert, Paul W H I Parren. Nat Rev Drug Discov 2019
445
11

Targeted Intracellular Delivery of Antibodies: The State of the Art.
Tatiana A Slastnikova, A V Ulasov, A A Rosenkranz, A S Sobolev. Front Pharmacol 2018
93
11

Development of therapeutic antibodies for the treatment of diseases.
Ruei-Min Lu, Yu-Chyi Hwang, I-Ju Liu, Chi-Chiu Lee, Han-Zen Tsai, Hsin-Jung Li, Han-Chung Wu. J Biomed Sci 2020
578
11

Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index.
Robert P Lyon, Tim D Bovee, Svetlana O Doronina, Patrick J Burke, Joshua H Hunter, Haley D Neff-LaFord, Mechthild Jonas, Martha E Anderson, Jocelyn R Setter, Peter D Senter. Nat Biotechnol 2015
254
11

Antibody-Drug Conjugates-A Tutorial Review.
Stephanie Baah, Mark Laws, Khondaker Miraz Rahman. Molecules 2021
23
11

Dolaflexin: A Novel Antibody-Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect.
Aleksandr V Yurkovetskiy, Natalya D Bodyak, Mao Yin, Joshua D Thomas, Susan M Clardy, Patrick R Conlon, Cheri A Stevenson, Alex Uttard, LiuLiang Qin, Dmitry R Gumerov,[...]. Mol Cancer Ther 2021
19
11

Antibody-drug conjugates--an emerging class of cancer treatment.
Nikolaos Diamantis, Udai Banerji. Br J Cancer 2016
280
11




Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications.
Nirnoy Dan, Saini Setua, Vivek K Kashyap, Sheema Khan, Meena Jaggi, Murali M Yallapu, Subhash C Chauhan. Pharmaceuticals (Basel) 2018
108
11

Antibody-Drug Conjugates: A Comprehensive Review.
Puregmaa Khongorzul, Cai Jia Ling, Farhan Ullah Khan, Awais Ullah Ihsan, Juan Zhang. Mol Cancer Res 2020
209
11

Antibody-drug conjugates: Recent advances in linker chemistry.
Zheng Su, Dian Xiao, Fei Xie, Lianqi Liu, Yanming Wang, Shiyong Fan, Xinbo Zhou, Song Li. Acta Pharm Sin B 2021
22
11

The state of the art of bispecific antibodies for treating human malignancies.
Shuhang Wang, Kun Chen, Qi Lei, Peiwen Ma, Andy Qingan Yuan, Yong Zhao, Youwei Jiang, Hong Fang, Shujun Xing, Yuan Fang,[...]. EMBO Mol Med 2021
18
11

Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis.
Hyo Jung Park, Kyung Won Kim, Junhee Pyo, Chong Hyun Suh, Shinkyo Yoon, Hiroto Hatabu, Mizuki Nishino. Radiology 2020
36
11

Novel patterns of response under immunotherapy.
E Borcoman, Y Kanjanapan, S Champiat, S Kato, V Servois, R Kurzrock, S Goel, P Bedard, C Le Tourneau. Ann Oncol 2019
212
11

Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
Eric Shifrut, Julia Carnevale, Victoria Tobin, Theodore L Roth, Jonathan M Woo, Christina T Bui, P Jonathan Li, Morgan E Diolaiti, Alan Ashworth, Alexander Marson. Cell 2018
206
11

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.
David L Porter, Bruce L Levine, Michael Kalos, Adam Bagg, Carl H June. N Engl J Med 2011
11

CAR-T cell therapy: current limitations and potential strategies.
Robert C Sterner, Rosalie M Sterner. Blood Cancer J 2021
204
11

A review of bispecific antibodies and antibody constructs in oncology and clinical challenges.
Frans V Suurs, Marjolijn N Lub-de Hooge, Elisabeth G E de Vries, Derk Jan A de Groot. Pharmacol Ther 2019
115
11

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.
Qing Zhou, Meghan E Munger, Rachelle G Veenstra, Brenda J Weigel, Mitsuomi Hirashima, David H Munn, William J Murphy, Miyuki Azuma, Ana C Anderson, Vijay K Kuchroo,[...]. Blood 2011
445
11

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.
Jun Wang, Miguel F Sanmamed, Ila Datar, Tina Tianjiao Su, Lan Ji, Jingwei Sun, Ling Chen, Yusheng Chen, Gefeng Zhu, Weiwei Yin,[...]. Cell 2019
354
11


Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia.
Marina Wierz, Sandrine Pierson, Léa Guyonnet, Elodie Viry, Audrey Lequeux, Anaïs Oudin, Simone P Niclou, Markus Ollert, Guy Berchem, Bassam Janji,[...]. Blood 2018
76
11

Engineered antibody fragments and the rise of single domains.
Philipp Holliger, Peter J Hudson. Nat Biotechnol 2005
11

The state-of-play and future of antibody therapeutics.
Zehra Elgundi, Mouhamad Reslan, Esteban Cruz, Vicki Sifniotis, Veysel Kayser. Adv Drug Deliv Rev 2017
156
11

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.
Adrienne H Long, Waleed M Haso, Jack F Shern, Kelsey M Wanhainen, Meera Murgai, Maria Ingaramo, Jillian P Smith, Alec J Walker, M Eric Kohler, Vikas R Venkateshwara,[...]. Nat Med 2015
884
11

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Avery D Posey, Robert D Schwab, Alina C Boesteanu, Catharina Steentoft, Ulla Mandel, Boris Engels, Jennifer D Stone, Thomas D Madsen, Karin Schreiber, Kathleen M Haines,[...]. Immunity 2016
325
11


Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.
Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, William Wierda, Cristina Gutierrez, Frederick L Locke, Krishna V Komanduri, Yi Lin, Nitin Jain, Naval Daver,[...]. Nat Rev Clin Oncol 2018
11

Phage antibodies: filamentous phage displaying antibody variable domains.
J McCafferty, A D Griffiths, G Winter, D J Chiswell. Nature 1990
5

A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks.
A S Greenberg, D Avila, M Hughes, A Hughes, E C McKinney, M F Flajnik. Nature 1995
477
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.